Drug cocktail made and marketed by Indian pharma companies such as Ranbaxy and Cipla has proven to be more effective than any other drugs:
A three-year study of AIDS drugs has identified what the research leaders believe is the ideal triple-therapy cocktail for new patients.
The successful cocktail, known colloquially as "two nukes plus a non-nuke," is the same one that the World Health Organization has been recommending in poor countries since 2002. It is also the same combination that Indian suppliers of generic drugs have been putting in three-in-one pills since 2001.
Another drug cocktail examined in the study — a "three-nuke combination" — did so poorly that patients were taken off it. The failed cocktail is the only one made as a three-in-one pill by any Western pharmaceutical company.
Click here for the rest of the piece. This is good news for India since AIDS has been identified as one of the most deadliest disease confronting the country in recent times. The availability of cheap drugs is a good first step.